Zobrazeno 1 - 10
of 52
pro vyhledávání: '"J.-Y. Bosc"'
Autor:
O. Gilbert, F. Saïdani, J Y Bosc, N. Kerkeni, M. Cuny, Annie Rodriguez, Jean-Paul Cristol, Hélène Leray-Moragues, L. Chalabi, N. Raynal
Publikováno v:
Néphrologie & Thérapeutique. 17:357-358
Introduction La reponse humorale a la vaccination anti-COVID des dialyses reste incertaine de meme que la strategie vaccinale a adopter. Description Sur une cohorte de 600 patients dialyses ayant recu deux doses de vaccin a ARNm, nous avons dose dans
Autor:
C. Turc-Baron, C. Guiraud, N. Kerkeni, E. Ricard, L. Chalabi, M. Cuny, N. Raynal, Hélène Leray-Moragues, J Y Bosc, Annie Rodriguez
Publikováno v:
Nephrologie & Therapeutique
Introduction Nos patients dialysés ont été particulièrement exposés à la pandémie de COVID-19. Description Nous rapportons une étude observationnelle rétrospective de notre cohorte de patients hémodialysés repliés en secteur COVID de mars
Autor:
J.-Y. Bosc
Publikováno v:
JMV-Journal de Médecine Vasculaire. 43:79-80
Le bilan vasculaire exhaustif est un prerequis desormais recommande pour toutes creations d’abords vasculaires d’hemodialyse. Etape cle de ce bilan, la cartographie ultrasonique reste indissociable de l’interrogatoire et de l’examen clinique.
Autor:
Ciro Tetta, Jean-Paul Cristol, Bernard Canaud, Bernard Descomps, J Y Bosc, Claude-Louis Leger, Marion Morena, Cécile Delcourt, Gilles Forret, Laure Papoz
Publikováno v:
Nephrology Dialysis Transplantation. 17:422-427
Enhanced oxidative stress in haemodialysis (HD) patients may be considered as a risk factor for accelerated atherosclerosis. Reduced antioxidant defences include impairment in enzyme activities and decreased plasma levels of hydrophilic vitamin C (vi
Publikováno v:
Nephrology Dialysis Transplantation. 15:21-30
Dialysate purity has become a major concern in recent years since it was shown that low levels of endotoxin in dialysate were able to induce the production of proinflammatory cytokines, which were putatively implicated in the development of dialysis-
Autor:
J Y Bosc, Bernard Canaud, Hélène Leray-Moragues, Guiseppe Verzetti, Karl Thomaseth, Laurent Cabrol, Carlo Navino
Publikováno v:
Scopus-Elsevier
Urea as a marker of adequacy in hemodialysis: Lesson from in vivo urea dynamics monitoring. Background "Dialysis dose," a concept developed by Sargent and Gotch based on urea kinetic modeling, is a useful and recognized tool that is used to quantitat
Autor:
J Y Bosc, Laurie J. Garred, Fabrice Vaussenat, Martine Leblanc, Hélène Leray-Moragues, Bernard Canaud
Publikováno v:
Nephrology Dialysis Transplantation. 15:511-516
INTRODUCTION During real-time monitoring of the ultrafiltration coefficient (Kuf) in haemodiafiltration (HDF), it was noticed that the ultrafiltration performance of polysulphone membrane dialysers increased when hypertonic glucose (D50%) was adminis
Autor:
F. Stec, J Y Bosc, Hélène Leray-Moragues, Charles Mion, A. Argilés, Bernard Canaud, Martine Leblanc
Publikováno v:
Nephrology Dialysis Transplantation. 15:60-67
Publikováno v:
Blood Purification. 18:200-213
Dialysate purity has become a major concern in hemodialysis since it has been shown that microbial-derived products were stimulating the production and the release of proinflammatory cytokines in hemodialysis patients. This chronic microinflammatory
Publikováno v:
Nephrology Dialysis Transplantation. 13:3-11
Faced with the shortcomings of conventional and routinely performed treatment modality for end- dialysis on a long-term basis, as illustrated by the stage renal failure ( ESRF ) patients. Long-term dialysis dialysis-related pathology, a need for a ne